REFERENCES
1. Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology . 5th ed. Lippincott Williams & Wilkins; 2006.
2. Arora R, Arora B. Acute leukemia in children: A review of the current Indian data. South Asian J Cancer . 2016;5(3):155. doi:10.4103/2278-330X.187591
3. Haddy TB, Mosher RB, Reaman GH. Late effects in long-term survivors after treatment for childhood acute leukemia. Clin Pediatr (Phila) . 2009;48(6):601-608. doi:10.1177/0009922809332680
4. Krull KR, Brinkman TM, Li C, et al. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study. J Clin Oncol Off J Am Soc Clin Oncol . 2013;31(35):4407-4415. doi:10.1200/JCO.2012.48.2315
5. Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol Stockh Swed . 2007;46(4):417-432. doi:10.1080/02841860701367878
6. Denlinger CS, Carlson RW, Are M, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN . 2014;12(1):34-45. doi:10.6004/jnccn.2014.0005
7. Ganguli M, Blacker D, Blazer DG, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry . 2011;19(3):205-210. doi:10.1097/jgp.0b013e3182051ab4
8. Sharma R. Revised Kuppuswamy’s Socioeconomic Status Scale: Explained and Updated. Indian Pediatr . 2017;54(10):867-870.
9. Wechsler D. WISC-IV India. Wechsler intelligence scale for children - fourth (India edition) New Delhi: Pearson; 2016. https://pearsonclinical.in/solutions/wisc-iv-india-complete-kit/
10. Mulrooney DA, Hyun G, Ness KK, et al. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study. Lancet Haematol . 2019;6(6):e306-e316. doi:10.1016/S2352-3026(19)30050-X
11. Kim SJ, Park MH, Lee JW, et al. Neurocognitive Outcome in Survivors of Childhood Acute Lymphoblastic Leukemia: Experience at a Tertiary Care Hospital in Korea. J Korean Med Sci . 2015;30(4):463. doi:10.3346/jkms.2015.30.4.463
12. Kanellopoulos A, Andersson S, Zeller B, et al. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only: Very Long-Term Cognitive Outcome After Childhood ALL. Pediatr Blood Cancer . 2016;63(1):133-138. doi:10.1002/pbc.25690
13. Peng L, Yam PP-Y, Yang LS, Sato S, Li CK, Cheung YT. Neurocognitive impairment in Asian childhood cancer survivors: a systematic review.Cancer Metastasis Rev . 2020;39(1):27-41. doi:10.1007/s10555-020-09857-y
14. Kurkure P, Achrekar S, Dalvi N, Goswami S. Childhood cancer survivors–living beyond cure. Indian J Pediatr . 2003;70(10):825-828. doi:10.1007/BF02723807
15. Fletcher JM, Copeland DR. Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol . 1988;10(4):495-537. doi:10.1080/01688638808408255
16. Edelstein K, DʼAgostino N, Bernstein LJ, et al. Long-term Neurocognitive Outcomes in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: J Pediatr Hematol Oncol . 2011;33(6):450-458. doi:10.1097/MPH.0b013e31820d86f2
17. Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol . 2017;13(1):52-64. doi:10.1038/nrneurol.2016.185
18. Pui C-H, Campana D, Pei D, et al. Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation. N Engl J Med . 2009;360(26):2730-2741. doi:10.1056/NEJMoa0900386
19. Cheung YT, Krull KR. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review. Neurosci Biobehav Rev . 2015;53:108-120. doi:10.1016/j.neubiorev.2015.03.016
20. Armstrong FD. Acute leukodystrophy: elevated risk for neurocognitive impairment and imaging abnormalities. Lancet Haematol . 2016;3(10):e447-e448. doi:10.1016/S2352-3026(16)30129-6
21. Krull KR, Cheung YT, Liu W, et al. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia. J Clin Oncol . 2016;34(22):2644-2653. doi:10.1200/JCO.2015.65.4574
22. Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive Outcomes Following Contemporary Treatment Without Cranial Irradiation for Childhood Acute Lymphoblastic Leukemia. JNCI J Natl Cancer Inst . 2012;104(18):1386-1395. doi:10.1093/jnci/djs344
23. van der Plas E, Nieman BJ, Butcher DT, et al. Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on Methotrexate. J Can Acad Child Adolesc Psychiatry J Acad Can Psychiatr Enfant Adolesc . 2015;24(1):25-32.
24. Krull KR. Dexamethasone and neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer . 2020;67(3). doi:10.1002/pbc.28118
25. Kadan-Lottick NS, Brouwers P, Breiger D, et al. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood . 2009;114(9):1746-1752. doi:10.1182/blood-2008-12-186502
26. Caron JE, Krull KR, Hockenberry M, Jain N, Kaemingk K, Moore IM. Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer . 2009;53(4):551-556. doi:10.1002/pbc.22128
27. Protas P, Holownia A, Muszynska-Roslan K, Wielgat P, Krawczuk-Rybak M, Braszko J. Cerebrospinal Fluid IL-6, TNF-α and MCP-1 in Children with Acute Lymphoblastic Leukaemia during Chemotherapy.Neuropediatrics . 2011;42(06):254-256. doi:10.1055/s-0031-1295477
28. Cheung YT, Khan RB, Liu W, et al. Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia. JAMA Oncol . 2018;4(7):e180089. doi:10.1001/jamaoncol.2018.0089
29. Landier W, Skinner R, Wallace WH, et al. Surveillance for Late Effects in Childhood Cancer Survivors. J Clin Oncol Off J Am Soc Clin Oncol . 2018;36(21):2216-2222. doi:10.1200/JCO.2017.77.0180
30. Jacola LM, Edelstein K, Liu W, et al. Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study. Lancet Psychiatry . 2016;3(10):965-972. doi:10.1016/S2215-0366(16)30283-8
31. Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR. Neurocognitive Outcomes and Interventions in Long-Term Survivors of Childhood Cancer. J Clin Oncol . 2018;36(21):2181-2189. doi:10.1200/JCO.2017.76.4696
32. Sleurs C, Madoe A, Lagae L, et al. Genetic Modulation of Neurocognitive Development in Cancer Patients throughout the Lifespan: a Systematic Review. Neuropsychol Rev . 2019;29(2):190-219. doi:10.1007/s11065-019-09399-3
33. Sharkey CM, Clawson AH, Mullins LL, et al. The relationship of child executive functions to parenting capacities in childhood acute lymphoblastic leukemia survivors. Pediatr Blood Cancer . 2019;66(8). doi:10.1002/pbc.27761
34. Huang I-C, Brinkman TM, Kenzik K, et al. Association Between the Prevalence of Symptoms and Health-Related Quality of Life in Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study. J Clin Oncol . 2013;31(33):4242-4251. doi:10.1200/JCO.2012.47.8867
35. Thompson SJ, Leigh L, Christensen R, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol Off J Am Soc Clin Oncol . 2001;19(6):1802-1808. doi:10.1200/JCO.2001.19.6.1802